These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 27898360)
1. Novel oral administrated paclitaxel micelles with enhanced bioavailability and antitumor efficacy for resistant breast cancer. Zhang T; Luo J; Fu Y; Li H; Ding R; Gong T; Zhang Z Colloids Surf B Biointerfaces; 2017 Feb; 150():89-97. PubMed ID: 27898360 [TBL] [Abstract][Full Text] [Related]
2. The antitumor efficacy of functional paclitaxel nanomicelles in treating resistant breast cancers by oral delivery. Yao HJ; Ju RJ; Wang XX; Zhang Y; Li RJ; Yu Y; Zhang L; Lu WL Biomaterials; 2011 Apr; 32(12):3285-302. PubMed ID: 21306774 [TBL] [Abstract][Full Text] [Related]
3. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery. Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751 [TBL] [Abstract][Full Text] [Related]
4. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance. Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367 [TBL] [Abstract][Full Text] [Related]
5. A multistage oral delivery system of PTX for improving oral bioavailability and enhancing anticancer efficacy. Zhao T; Zhou H; Wu W; Song X; Gong T Drug Dev Ind Pharm; 2021 Feb; 47(2):259-267. PubMed ID: 33501858 [TBL] [Abstract][Full Text] [Related]
6. Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via Novel Soluplus(®)-Solutol(®) HS15 binary mixed micelles system. Hou J; Sun E; Sun C; Wang J; Yang L; Jia XB; Zhang ZH Int J Pharm; 2016 Oct; 512(1):186-193. PubMed ID: 27567930 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
8. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells. Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
10. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously. Li X; Li P; Zhang Y; Zhou Y; Chen X; Huang Y; Liu Y Pharm Res; 2010 Aug; 27(8):1498-511. PubMed ID: 20411408 [TBL] [Abstract][Full Text] [Related]
11. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related]
12. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel. Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684 [TBL] [Abstract][Full Text] [Related]
13. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319 [TBL] [Abstract][Full Text] [Related]
15. Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Wang Z; Li X; Wang D; Zou Y; Qu X; He C; Deng Y; Jin Y; Zhou Y; Zhou Y; Liu Y Acta Biomater; 2017 Oct; 62():144-156. PubMed ID: 28842335 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of paclitaxel hybrid nanomicelles to treat resistant breast cancer via oral administration. Dian LH; Hu YJ; Lin JY; Zhang JY; Yan Y; Cui YN; Su ZB; Lu WL Int J Nanomedicine; 2018; 13():719-731. PubMed ID: 29440897 [TBL] [Abstract][Full Text] [Related]
17. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Mo R; Jin X; Li N; Ju C; Sun M; Zhang C; Ping Q Biomaterials; 2011 Jul; 32(20):4609-20. PubMed ID: 21440934 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy. Ji W; Wang B; Fan Q; Xu C; He Y; Chen Y PLoS One; 2017; 12(7):e0180037. PubMed ID: 28686704 [TBL] [Abstract][Full Text] [Related]
20. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]